nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CYP2B6—Raloxifene—osteoporosis	0.0609	0.107	CbGbCtD
Citalopram—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0588	0.103	CbGbCtD
Citalopram—CYP1A2—Estropipate—osteoporosis	0.0535	0.0938	CbGbCtD
Citalopram—CYP2B6—Cholecalciferol—osteoporosis	0.047	0.0824	CbGbCtD
Citalopram—ABCB1—Ethinyl Estradiol—osteoporosis	0.0301	0.0528	CbGbCtD
Citalopram—CYP2C19—Cholecalciferol—osteoporosis	0.0299	0.0523	CbGbCtD
Citalopram—CYP3A4—Estropipate—osteoporosis	0.028	0.0491	CbGbCtD
Citalopram—CYP3A4—Calcitriol—osteoporosis	0.028	0.0491	CbGbCtD
Citalopram—CYP1A2—Conjugated Estrogens—osteoporosis	0.0253	0.0443	CbGbCtD
Citalopram—CYP2C19—Estradiol—osteoporosis	0.0241	0.0422	CbGbCtD
Citalopram—CYP2D6—Cholecalciferol—osteoporosis	0.0227	0.0398	CbGbCtD
Citalopram—CYP3A4—Ergocalciferol—osteoporosis	0.0224	0.0393	CbGbCtD
Citalopram—CYP1A2—Estradiol—osteoporosis	0.0222	0.0389	CbGbCtD
Citalopram—ABCB1—Conjugated Estrogens—osteoporosis	0.0221	0.0388	CbGbCtD
Citalopram—ABCB1—Estradiol—osteoporosis	0.0194	0.034	CbGbCtD
Citalopram—CYP3A4—Raloxifene—osteoporosis	0.0187	0.0328	CbGbCtD
Citalopram—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0181	0.0317	CbGbCtD
Citalopram—CYP3A4—Cholecalciferol—osteoporosis	0.0144	0.0253	CbGbCtD
Citalopram—CYP3A4—Conjugated Estrogens—osteoporosis	0.0133	0.0232	CbGbCtD
Citalopram—CYP3A4—Estradiol—osteoporosis	0.0116	0.0204	CbGbCtD
Citalopram—Pruritus—Alendronate—osteoporosis	9.54e-05	0.000245	CcSEcCtD
Citalopram—Dyspepsia—Risedronate—osteoporosis	9.52e-05	0.000244	CcSEcCtD
Citalopram—Eye disorder—Estradiol—osteoporosis	9.52e-05	0.000244	CcSEcCtD
Citalopram—Tinnitus—Estradiol—osteoporosis	9.5e-05	0.000244	CcSEcCtD
Citalopram—Constipation—Ethinyl Estradiol—osteoporosis	9.49e-05	0.000243	CcSEcCtD
Citalopram—Confusional state—Zoledronate—osteoporosis	9.47e-05	0.000243	CcSEcCtD
Citalopram—Hypersensitivity—Calcitriol—osteoporosis	9.47e-05	0.000243	CcSEcCtD
Citalopram—Flushing—Estradiol—osteoporosis	9.46e-05	0.000243	CcSEcCtD
Citalopram—Cardiac disorder—Estradiol—osteoporosis	9.46e-05	0.000243	CcSEcCtD
Citalopram—Arthralgia—Conjugated Estrogens—osteoporosis	9.44e-05	0.000242	CcSEcCtD
Citalopram—Myalgia—Conjugated Estrogens—osteoporosis	9.44e-05	0.000242	CcSEcCtD
Citalopram—Chest pain—Conjugated Estrogens—osteoporosis	9.44e-05	0.000242	CcSEcCtD
Citalopram—Asthenia—Ibandronate—osteoporosis	9.42e-05	0.000242	CcSEcCtD
Citalopram—Anxiety—Conjugated Estrogens—osteoporosis	9.4e-05	0.000241	CcSEcCtD
Citalopram—Nausea—Etidronic acid—osteoporosis	9.4e-05	0.000241	CcSEcCtD
Citalopram—Anaphylactic shock—Zoledronate—osteoporosis	9.4e-05	0.000241	CcSEcCtD
Citalopram—Oedema—Zoledronate—osteoporosis	9.4e-05	0.000241	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	9.37e-05	0.00024	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Pamidronate—osteoporosis	9.37e-05	0.00024	CcSEcCtD
Citalopram—Diarrhoea—Estropipate—osteoporosis	9.37e-05	0.00024	CcSEcCtD
Citalopram—Gastrointestinal disorder—Risedronate—osteoporosis	9.34e-05	0.00024	CcSEcCtD
Citalopram—Infection—Zoledronate—osteoporosis	9.33e-05	0.000239	CcSEcCtD
Citalopram—Fatigue—Risedronate—osteoporosis	9.33e-05	0.000239	CcSEcCtD
Citalopram—Insomnia—Pamidronate—osteoporosis	9.3e-05	0.000239	CcSEcCtD
Citalopram—Pruritus—Ibandronate—osteoporosis	9.29e-05	0.000238	CcSEcCtD
Citalopram—Constipation—Risedronate—osteoporosis	9.25e-05	0.000237	CcSEcCtD
Citalopram—Pain—Risedronate—osteoporosis	9.25e-05	0.000237	CcSEcCtD
Citalopram—Angiopathy—Estradiol—osteoporosis	9.25e-05	0.000237	CcSEcCtD
Citalopram—Shock—Zoledronate—osteoporosis	9.24e-05	0.000237	CcSEcCtD
Citalopram—Paraesthesia—Pamidronate—osteoporosis	9.24e-05	0.000237	CcSEcCtD
Citalopram—Diarrhoea—Alendronate—osteoporosis	9.23e-05	0.000237	CcSEcCtD
Citalopram—Asthenia—Calcitriol—osteoporosis	9.22e-05	0.000237	CcSEcCtD
Citalopram—Nervous system disorder—Zoledronate—osteoporosis	9.21e-05	0.000236	CcSEcCtD
Citalopram—Immune system disorder—Estradiol—osteoporosis	9.2e-05	0.000236	CcSEcCtD
Citalopram—Thrombocytopenia—Zoledronate—osteoporosis	9.2e-05	0.000236	CcSEcCtD
Citalopram—Mediastinal disorder—Estradiol—osteoporosis	9.18e-05	0.000236	CcSEcCtD
Citalopram—Dyspnoea—Pamidronate—osteoporosis	9.17e-05	0.000235	CcSEcCtD
Citalopram—Tachycardia—Zoledronate—osteoporosis	9.17e-05	0.000235	CcSEcCtD
Citalopram—Feeling abnormal—Ethinyl Estradiol—osteoporosis	9.14e-05	0.000235	CcSEcCtD
Citalopram—Chills—Estradiol—osteoporosis	9.14e-05	0.000235	CcSEcCtD
Citalopram—Somnolence—Pamidronate—osteoporosis	9.14e-05	0.000235	CcSEcCtD
Citalopram—Skin disorder—Zoledronate—osteoporosis	9.13e-05	0.000234	CcSEcCtD
Citalopram—Pruritus—Calcitriol—osteoporosis	9.09e-05	0.000233	CcSEcCtD
Citalopram—Hyperhidrosis—Zoledronate—osteoporosis	9.08e-05	0.000233	CcSEcCtD
Citalopram—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	9.07e-05	0.000233	CcSEcCtD
Citalopram—Diarrhoea—Raloxifene—osteoporosis	9.07e-05	0.000233	CcSEcCtD
Citalopram—Dyspepsia—Pamidronate—osteoporosis	9.05e-05	0.000232	CcSEcCtD
Citalopram—Dizziness—Estropipate—osteoporosis	9.05e-05	0.000232	CcSEcCtD
Citalopram—Anaphylactic shock—Conjugated Estrogens—osteoporosis	9.05e-05	0.000232	CcSEcCtD
Citalopram—Oedema—Conjugated Estrogens—osteoporosis	9.05e-05	0.000232	CcSEcCtD
Citalopram—Alopecia—Estradiol—osteoporosis	9.01e-05	0.000231	CcSEcCtD
Citalopram—Infection—Conjugated Estrogens—osteoporosis	8.99e-05	0.000231	CcSEcCtD
Citalopram—Diarrhoea—Ibandronate—osteoporosis	8.98e-05	0.00023	CcSEcCtD
Citalopram—Anorexia—Zoledronate—osteoporosis	8.96e-05	0.00023	CcSEcCtD
Citalopram—Decreased appetite—Pamidronate—osteoporosis	8.94e-05	0.000229	CcSEcCtD
Citalopram—Mental disorder—Estradiol—osteoporosis	8.93e-05	0.000229	CcSEcCtD
Citalopram—Dizziness—Alendronate—osteoporosis	8.92e-05	0.000229	CcSEcCtD
Citalopram—Shock—Conjugated Estrogens—osteoporosis	8.9e-05	0.000228	CcSEcCtD
Citalopram—Gastrointestinal disorder—Pamidronate—osteoporosis	8.88e-05	0.000228	CcSEcCtD
Citalopram—Nervous system disorder—Conjugated Estrogens—osteoporosis	8.87e-05	0.000228	CcSEcCtD
Citalopram—Erythema—Estradiol—osteoporosis	8.87e-05	0.000228	CcSEcCtD
Citalopram—Malnutrition—Estradiol—osteoporosis	8.87e-05	0.000228	CcSEcCtD
Citalopram—Fatigue—Pamidronate—osteoporosis	8.87e-05	0.000227	CcSEcCtD
Citalopram—Gastrointestinal pain—Risedronate—osteoporosis	8.85e-05	0.000227	CcSEcCtD
Citalopram—Tachycardia—Conjugated Estrogens—osteoporosis	8.83e-05	0.000226	CcSEcCtD
Citalopram—Urticaria—Ethinyl Estradiol—osteoporosis	8.82e-05	0.000226	CcSEcCtD
Citalopram—Constipation—Pamidronate—osteoporosis	8.8e-05	0.000226	CcSEcCtD
Citalopram—Pain—Pamidronate—osteoporosis	8.8e-05	0.000226	CcSEcCtD
Citalopram—Diarrhoea—Calcitriol—osteoporosis	8.79e-05	0.000226	CcSEcCtD
Citalopram—Skin disorder—Conjugated Estrogens—osteoporosis	8.79e-05	0.000225	CcSEcCtD
Citalopram—Hypotension—Zoledronate—osteoporosis	8.78e-05	0.000225	CcSEcCtD
Citalopram—Abdominal pain—Ethinyl Estradiol—osteoporosis	8.77e-05	0.000225	CcSEcCtD
Citalopram—Body temperature increased—Ethinyl Estradiol—osteoporosis	8.77e-05	0.000225	CcSEcCtD
Citalopram—Dizziness—Raloxifene—osteoporosis	8.77e-05	0.000225	CcSEcCtD
Citalopram—Hyperhidrosis—Conjugated Estrogens—osteoporosis	8.75e-05	0.000224	CcSEcCtD
Citalopram—Flatulence—Estradiol—osteoporosis	8.74e-05	0.000224	CcSEcCtD
Citalopram—Tension—Estradiol—osteoporosis	8.71e-05	0.000223	CcSEcCtD
Citalopram—Vomiting—Estropipate—osteoporosis	8.71e-05	0.000223	CcSEcCtD
Citalopram—Dysgeusia—Estradiol—osteoporosis	8.69e-05	0.000223	CcSEcCtD
Citalopram—Dizziness—Ibandronate—osteoporosis	8.68e-05	0.000223	CcSEcCtD
Citalopram—Rash—Estropipate—osteoporosis	8.63e-05	0.000221	CcSEcCtD
Citalopram—Dermatitis—Estropipate—osteoporosis	8.62e-05	0.000221	CcSEcCtD
Citalopram—Anorexia—Conjugated Estrogens—osteoporosis	8.62e-05	0.000221	CcSEcCtD
Citalopram—Nervousness—Estradiol—osteoporosis	8.62e-05	0.000221	CcSEcCtD
Citalopram—Urticaria—Risedronate—osteoporosis	8.6e-05	0.00022	CcSEcCtD
Citalopram—Back pain—Estradiol—osteoporosis	8.58e-05	0.00022	CcSEcCtD
Citalopram—Headache—Estropipate—osteoporosis	8.58e-05	0.00022	CcSEcCtD
Citalopram—Vomiting—Alendronate—osteoporosis	8.57e-05	0.00022	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Zoledronate—osteoporosis	8.56e-05	0.00022	CcSEcCtD
Citalopram—Body temperature increased—Risedronate—osteoporosis	8.55e-05	0.000219	CcSEcCtD
Citalopram—Abdominal pain—Risedronate—osteoporosis	8.55e-05	0.000219	CcSEcCtD
Citalopram—Muscle spasms—Estradiol—osteoporosis	8.53e-05	0.000219	CcSEcCtD
Citalopram—Rash—Alendronate—osteoporosis	8.5e-05	0.000218	CcSEcCtD
Citalopram—Insomnia—Zoledronate—osteoporosis	8.5e-05	0.000218	CcSEcCtD
Citalopram—Dermatitis—Alendronate—osteoporosis	8.49e-05	0.000218	CcSEcCtD
Citalopram—Feeling abnormal—Pamidronate—osteoporosis	8.48e-05	0.000217	CcSEcCtD
Citalopram—Hypotension—Conjugated Estrogens—osteoporosis	8.45e-05	0.000217	CcSEcCtD
Citalopram—Headache—Alendronate—osteoporosis	8.45e-05	0.000217	CcSEcCtD
Citalopram—Paraesthesia—Zoledronate—osteoporosis	8.44e-05	0.000216	CcSEcCtD
Citalopram—Vomiting—Raloxifene—osteoporosis	8.43e-05	0.000216	CcSEcCtD
Citalopram—Gastrointestinal pain—Pamidronate—osteoporosis	8.41e-05	0.000216	CcSEcCtD
Citalopram—Dyspnoea—Zoledronate—osteoporosis	8.38e-05	0.000215	CcSEcCtD
Citalopram—Rash—Raloxifene—osteoporosis	8.36e-05	0.000214	CcSEcCtD
Citalopram—Dermatitis—Raloxifene—osteoporosis	8.35e-05	0.000214	CcSEcCtD
Citalopram—Somnolence—Zoledronate—osteoporosis	8.35e-05	0.000214	CcSEcCtD
Citalopram—Vomiting—Ibandronate—osteoporosis	8.35e-05	0.000214	CcSEcCtD
Citalopram—Tremor—Estradiol—osteoporosis	8.31e-05	0.000213	CcSEcCtD
Citalopram—Headache—Raloxifene—osteoporosis	8.31e-05	0.000213	CcSEcCtD
Citalopram—Rash—Ibandronate—osteoporosis	8.28e-05	0.000212	CcSEcCtD
Citalopram—Dermatitis—Ibandronate—osteoporosis	8.27e-05	0.000212	CcSEcCtD
Citalopram—Dyspepsia—Zoledronate—osteoporosis	8.27e-05	0.000212	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	8.24e-05	0.000211	CcSEcCtD
Citalopram—Ill-defined disorder—Estradiol—osteoporosis	8.23e-05	0.000211	CcSEcCtD
Citalopram—Headache—Ibandronate—osteoporosis	8.22e-05	0.000211	CcSEcCtD
Citalopram—Insomnia—Conjugated Estrogens—osteoporosis	8.18e-05	0.00021	CcSEcCtD
Citalopram—Hypersensitivity—Ethinyl Estradiol—osteoporosis	8.18e-05	0.00021	CcSEcCtD
Citalopram—Vomiting—Calcitriol—osteoporosis	8.17e-05	0.00021	CcSEcCtD
Citalopram—Decreased appetite—Zoledronate—osteoporosis	8.17e-05	0.000209	CcSEcCtD
Citalopram—Agitation—Estradiol—osteoporosis	8.15e-05	0.000209	CcSEcCtD
Citalopram—Nausea—Estropipate—osteoporosis	8.13e-05	0.000209	CcSEcCtD
Citalopram—Abdominal pain—Pamidronate—osteoporosis	8.13e-05	0.000209	CcSEcCtD
Citalopram—Body temperature increased—Pamidronate—osteoporosis	8.13e-05	0.000209	CcSEcCtD
Citalopram—Paraesthesia—Conjugated Estrogens—osteoporosis	8.12e-05	0.000208	CcSEcCtD
Citalopram—Gastrointestinal disorder—Zoledronate—osteoporosis	8.11e-05	0.000208	CcSEcCtD
Citalopram—Angioedema—Estradiol—osteoporosis	8.11e-05	0.000208	CcSEcCtD
Citalopram—Rash—Calcitriol—osteoporosis	8.1e-05	0.000208	CcSEcCtD
Citalopram—Fatigue—Zoledronate—osteoporosis	8.1e-05	0.000208	CcSEcCtD
Citalopram—Dermatitis—Calcitriol—osteoporosis	8.1e-05	0.000208	CcSEcCtD
Citalopram—Dyspnoea—Conjugated Estrogens—osteoporosis	8.07e-05	0.000207	CcSEcCtD
Citalopram—Headache—Calcitriol—osteoporosis	8.05e-05	0.000207	CcSEcCtD
Citalopram—Somnolence—Conjugated Estrogens—osteoporosis	8.04e-05	0.000206	CcSEcCtD
Citalopram—Pain—Zoledronate—osteoporosis	8.03e-05	0.000206	CcSEcCtD
Citalopram—Constipation—Zoledronate—osteoporosis	8.03e-05	0.000206	CcSEcCtD
Citalopram—Nausea—Alendronate—osteoporosis	8.01e-05	0.000205	CcSEcCtD
Citalopram—Malaise—Estradiol—osteoporosis	8e-05	0.000205	CcSEcCtD
Citalopram—Hypersensitivity—Risedronate—osteoporosis	7.97e-05	0.000204	CcSEcCtD
Citalopram—Vertigo—Estradiol—osteoporosis	7.97e-05	0.000204	CcSEcCtD
Citalopram—Dyspepsia—Conjugated Estrogens—osteoporosis	7.96e-05	0.000204	CcSEcCtD
Citalopram—Asthenia—Ethinyl Estradiol—osteoporosis	7.96e-05	0.000204	CcSEcCtD
Citalopram—Syncope—Estradiol—osteoporosis	7.96e-05	0.000204	CcSEcCtD
Citalopram—Nausea—Raloxifene—osteoporosis	7.88e-05	0.000202	CcSEcCtD
Citalopram—Decreased appetite—Conjugated Estrogens—osteoporosis	7.86e-05	0.000202	CcSEcCtD
Citalopram—Pruritus—Ethinyl Estradiol—osteoporosis	7.85e-05	0.000201	CcSEcCtD
Citalopram—Palpitations—Estradiol—osteoporosis	7.84e-05	0.000201	CcSEcCtD
Citalopram—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	7.81e-05	0.0002	CcSEcCtD
Citalopram—Fatigue—Conjugated Estrogens—osteoporosis	7.8e-05	0.0002	CcSEcCtD
Citalopram—Nausea—Ibandronate—osteoporosis	7.8e-05	0.0002	CcSEcCtD
Citalopram—Loss of consciousness—Estradiol—osteoporosis	7.8e-05	0.0002	CcSEcCtD
Citalopram—Asthenia—Risedronate—osteoporosis	7.76e-05	0.000199	CcSEcCtD
Citalopram—Feeling abnormal—Zoledronate—osteoporosis	7.74e-05	0.000199	CcSEcCtD
Citalopram—Cough—Estradiol—osteoporosis	7.74e-05	0.000199	CcSEcCtD
Citalopram—Pain—Conjugated Estrogens—osteoporosis	7.74e-05	0.000198	CcSEcCtD
Citalopram—Constipation—Conjugated Estrogens—osteoporosis	7.74e-05	0.000198	CcSEcCtD
Citalopram—Gastrointestinal pain—Zoledronate—osteoporosis	7.68e-05	0.000197	CcSEcCtD
Citalopram—Hypertension—Estradiol—osteoporosis	7.66e-05	0.000196	CcSEcCtD
Citalopram—Pruritus—Risedronate—osteoporosis	7.66e-05	0.000196	CcSEcCtD
Citalopram—Nausea—Calcitriol—osteoporosis	7.63e-05	0.000196	CcSEcCtD
Citalopram—Diarrhoea—Ethinyl Estradiol—osteoporosis	7.59e-05	0.000195	CcSEcCtD
Citalopram—Hypersensitivity—Pamidronate—osteoporosis	7.58e-05	0.000194	CcSEcCtD
Citalopram—Myalgia—Estradiol—osteoporosis	7.55e-05	0.000194	CcSEcCtD
Citalopram—Chest pain—Estradiol—osteoporosis	7.55e-05	0.000194	CcSEcCtD
Citalopram—Arthralgia—Estradiol—osteoporosis	7.55e-05	0.000194	CcSEcCtD
Citalopram—Anxiety—Estradiol—osteoporosis	7.53e-05	0.000193	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	7.5e-05	0.000192	CcSEcCtD
Citalopram—Urticaria—Zoledronate—osteoporosis	7.46e-05	0.000191	CcSEcCtD
Citalopram—Discomfort—Estradiol—osteoporosis	7.46e-05	0.000191	CcSEcCtD
Citalopram—Abdominal pain—Zoledronate—osteoporosis	7.43e-05	0.00019	CcSEcCtD
Citalopram—Body temperature increased—Zoledronate—osteoporosis	7.43e-05	0.00019	CcSEcCtD
Citalopram—Diarrhoea—Risedronate—osteoporosis	7.4e-05	0.00019	CcSEcCtD
Citalopram—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	7.4e-05	0.00019	CcSEcCtD
Citalopram—Dry mouth—Estradiol—osteoporosis	7.39e-05	0.000189	CcSEcCtD
Citalopram—Asthenia—Pamidronate—osteoporosis	7.38e-05	0.000189	CcSEcCtD
Citalopram—Dizziness—Ethinyl Estradiol—osteoporosis	7.34e-05	0.000188	CcSEcCtD
Citalopram—Confusional state—Estradiol—osteoporosis	7.3e-05	0.000187	CcSEcCtD
Citalopram—Pruritus—Pamidronate—osteoporosis	7.28e-05	0.000187	CcSEcCtD
Citalopram—Oedema—Estradiol—osteoporosis	7.24e-05	0.000186	CcSEcCtD
Citalopram—Anaphylactic shock—Estradiol—osteoporosis	7.24e-05	0.000186	CcSEcCtD
Citalopram—Infection—Estradiol—osteoporosis	7.19e-05	0.000184	CcSEcCtD
Citalopram—Urticaria—Conjugated Estrogens—osteoporosis	7.19e-05	0.000184	CcSEcCtD
Citalopram—Dizziness—Risedronate—osteoporosis	7.15e-05	0.000184	CcSEcCtD
Citalopram—Abdominal pain—Conjugated Estrogens—osteoporosis	7.15e-05	0.000183	CcSEcCtD
Citalopram—Body temperature increased—Conjugated Estrogens—osteoporosis	7.15e-05	0.000183	CcSEcCtD
Citalopram—Shock—Estradiol—osteoporosis	7.12e-05	0.000183	CcSEcCtD
Citalopram—Nervous system disorder—Estradiol—osteoporosis	7.1e-05	0.000182	CcSEcCtD
Citalopram—Tachycardia—Estradiol—osteoporosis	7.07e-05	0.000181	CcSEcCtD
Citalopram—Vomiting—Ethinyl Estradiol—osteoporosis	7.06e-05	0.000181	CcSEcCtD
Citalopram—Diarrhoea—Pamidronate—osteoporosis	7.04e-05	0.000181	CcSEcCtD
Citalopram—Skin disorder—Estradiol—osteoporosis	7.03e-05	0.00018	CcSEcCtD
Citalopram—Hyperhidrosis—Estradiol—osteoporosis	7e-05	0.00018	CcSEcCtD
Citalopram—Rash—Ethinyl Estradiol—osteoporosis	7e-05	0.000179	CcSEcCtD
Citalopram—Dermatitis—Ethinyl Estradiol—osteoporosis	6.99e-05	0.000179	CcSEcCtD
Citalopram—Headache—Ethinyl Estradiol—osteoporosis	6.95e-05	0.000178	CcSEcCtD
Citalopram—Hypersensitivity—Zoledronate—osteoporosis	6.92e-05	0.000178	CcSEcCtD
Citalopram—Vomiting—Risedronate—osteoporosis	6.88e-05	0.000176	CcSEcCtD
Citalopram—Rash—Risedronate—osteoporosis	6.82e-05	0.000175	CcSEcCtD
Citalopram—Dermatitis—Risedronate—osteoporosis	6.82e-05	0.000175	CcSEcCtD
Citalopram—Dizziness—Pamidronate—osteoporosis	6.8e-05	0.000174	CcSEcCtD
Citalopram—Headache—Risedronate—osteoporosis	6.78e-05	0.000174	CcSEcCtD
Citalopram—Asthenia—Zoledronate—osteoporosis	6.74e-05	0.000173	CcSEcCtD
Citalopram—Hypersensitivity—Conjugated Estrogens—osteoporosis	6.67e-05	0.000171	CcSEcCtD
Citalopram—Pruritus—Zoledronate—osteoporosis	6.65e-05	0.00017	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Estradiol—osteoporosis	6.6e-05	0.000169	CcSEcCtD
Citalopram—Nausea—Ethinyl Estradiol—osteoporosis	6.59e-05	0.000169	CcSEcCtD
Citalopram—Insomnia—Estradiol—osteoporosis	6.55e-05	0.000168	CcSEcCtD
Citalopram—Vomiting—Pamidronate—osteoporosis	6.54e-05	0.000168	CcSEcCtD
Citalopram—Paraesthesia—Estradiol—osteoporosis	6.5e-05	0.000167	CcSEcCtD
Citalopram—Asthenia—Conjugated Estrogens—osteoporosis	6.49e-05	0.000166	CcSEcCtD
Citalopram—Rash—Pamidronate—osteoporosis	6.49e-05	0.000166	CcSEcCtD
Citalopram—Dermatitis—Pamidronate—osteoporosis	6.48e-05	0.000166	CcSEcCtD
Citalopram—Dyspnoea—Estradiol—osteoporosis	6.45e-05	0.000166	CcSEcCtD
Citalopram—Headache—Pamidronate—osteoporosis	6.44e-05	0.000165	CcSEcCtD
Citalopram—Somnolence—Estradiol—osteoporosis	6.44e-05	0.000165	CcSEcCtD
Citalopram—Diarrhoea—Zoledronate—osteoporosis	6.43e-05	0.000165	CcSEcCtD
Citalopram—Nausea—Risedronate—osteoporosis	6.43e-05	0.000165	CcSEcCtD
Citalopram—Pruritus—Conjugated Estrogens—osteoporosis	6.4e-05	0.000164	CcSEcCtD
Citalopram—Dyspepsia—Estradiol—osteoporosis	6.37e-05	0.000163	CcSEcCtD
Citalopram—Decreased appetite—Estradiol—osteoporosis	6.29e-05	0.000161	CcSEcCtD
Citalopram—Gastrointestinal disorder—Estradiol—osteoporosis	6.25e-05	0.00016	CcSEcCtD
Citalopram—Fatigue—Estradiol—osteoporosis	6.24e-05	0.00016	CcSEcCtD
Citalopram—Dizziness—Zoledronate—osteoporosis	6.21e-05	0.000159	CcSEcCtD
Citalopram—Constipation—Estradiol—osteoporosis	6.19e-05	0.000159	CcSEcCtD
Citalopram—Pain—Estradiol—osteoporosis	6.19e-05	0.000159	CcSEcCtD
Citalopram—Diarrhoea—Conjugated Estrogens—osteoporosis	6.19e-05	0.000159	CcSEcCtD
Citalopram—Nausea—Pamidronate—osteoporosis	6.11e-05	0.000157	CcSEcCtD
Citalopram—Dizziness—Conjugated Estrogens—osteoporosis	5.98e-05	0.000153	CcSEcCtD
Citalopram—Vomiting—Zoledronate—osteoporosis	5.97e-05	0.000153	CcSEcCtD
Citalopram—Feeling abnormal—Estradiol—osteoporosis	5.97e-05	0.000153	CcSEcCtD
Citalopram—Rash—Zoledronate—osteoporosis	5.92e-05	0.000152	CcSEcCtD
Citalopram—Gastrointestinal pain—Estradiol—osteoporosis	5.92e-05	0.000152	CcSEcCtD
Citalopram—Dermatitis—Zoledronate—osteoporosis	5.92e-05	0.000152	CcSEcCtD
Citalopram—Headache—Zoledronate—osteoporosis	5.89e-05	0.000151	CcSEcCtD
Citalopram—Vomiting—Conjugated Estrogens—osteoporosis	5.75e-05	0.000148	CcSEcCtD
Citalopram—Urticaria—Estradiol—osteoporosis	5.75e-05	0.000148	CcSEcCtD
Citalopram—Body temperature increased—Estradiol—osteoporosis	5.72e-05	0.000147	CcSEcCtD
Citalopram—Abdominal pain—Estradiol—osteoporosis	5.72e-05	0.000147	CcSEcCtD
Citalopram—Rash—Conjugated Estrogens—osteoporosis	5.7e-05	0.000146	CcSEcCtD
Citalopram—Dermatitis—Conjugated Estrogens—osteoporosis	5.7e-05	0.000146	CcSEcCtD
Citalopram—Headache—Conjugated Estrogens—osteoporosis	5.67e-05	0.000145	CcSEcCtD
Citalopram—Nausea—Zoledronate—osteoporosis	5.58e-05	0.000143	CcSEcCtD
Citalopram—Nausea—Conjugated Estrogens—osteoporosis	5.37e-05	0.000138	CcSEcCtD
Citalopram—Hypersensitivity—Estradiol—osteoporosis	5.33e-05	0.000137	CcSEcCtD
Citalopram—Asthenia—Estradiol—osteoporosis	5.19e-05	0.000133	CcSEcCtD
Citalopram—Pruritus—Estradiol—osteoporosis	5.12e-05	0.000131	CcSEcCtD
Citalopram—Diarrhoea—Estradiol—osteoporosis	4.95e-05	0.000127	CcSEcCtD
Citalopram—Dizziness—Estradiol—osteoporosis	4.79e-05	0.000123	CcSEcCtD
Citalopram—Vomiting—Estradiol—osteoporosis	4.6e-05	0.000118	CcSEcCtD
Citalopram—Rash—Estradiol—osteoporosis	4.57e-05	0.000117	CcSEcCtD
Citalopram—Dermatitis—Estradiol—osteoporosis	4.56e-05	0.000117	CcSEcCtD
Citalopram—Headache—Estradiol—osteoporosis	4.54e-05	0.000116	CcSEcCtD
Citalopram—Nausea—Estradiol—osteoporosis	4.3e-05	0.00011	CcSEcCtD
Citalopram—CYP2E1—Metabolism—TPI1—osteoporosis	1.96e-05	0.000494	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MGLL—osteoporosis	1.92e-05	0.000485	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—WNT1—osteoporosis	1.89e-05	0.000478	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—P4HB—osteoporosis	1.88e-05	0.000475	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—POMC—osteoporosis	1.86e-05	0.000468	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GAPDH—osteoporosis	1.85e-05	0.000466	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—P4HB—osteoporosis	1.84e-05	0.000465	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—FGA—osteoporosis	1.84e-05	0.000465	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—P4HB—osteoporosis	1.84e-05	0.000464	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—P4HB—osteoporosis	1.83e-05	0.000463	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—IL6—osteoporosis	1.83e-05	0.000461	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—ADCY5—osteoporosis	1.81e-05	0.000458	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GAPDH—osteoporosis	1.81e-05	0.000456	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—P4HB—osteoporosis	1.81e-05	0.000456	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—RAP1A—osteoporosis	1.8e-05	0.000454	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PTH—osteoporosis	1.79e-05	0.000452	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PTH—osteoporosis	1.78e-05	0.00045	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—IDH2—osteoporosis	1.78e-05	0.000449	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—RAP1A—osteoporosis	1.76e-05	0.000444	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RAP1A—osteoporosis	1.76e-05	0.000444	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PTH—osteoporosis	1.76e-05	0.000443	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RAP1A—osteoporosis	1.75e-05	0.000442	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PKM—osteoporosis	1.75e-05	0.000442	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—FDPS—osteoporosis	1.75e-05	0.000442	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CNR2—osteoporosis	1.74e-05	0.00044	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CNR2—osteoporosis	1.74e-05	0.000439	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.74e-05	0.000438	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—IDH2—osteoporosis	1.74e-05	0.000438	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—ADCY5—osteoporosis	1.73e-05	0.000437	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.73e-05	0.000437	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	1.73e-05	0.000436	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	1.73e-05	0.000435	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NFATC1—osteoporosis	1.72e-05	0.000433	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PTHLH—osteoporosis	1.71e-05	0.000432	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—BMP2—osteoporosis	1.71e-05	0.000432	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CNR2—osteoporosis	1.71e-05	0.000432	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NFATC1—osteoporosis	1.71e-05	0.000432	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.7e-05	0.00043	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—DKK1—osteoporosis	1.7e-05	0.00043	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	1.7e-05	0.000429	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—DKK1—osteoporosis	1.7e-05	0.000428	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	1.68e-05	0.000425	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—FGB—osteoporosis	1.68e-05	0.000423	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CA2—osteoporosis	1.67e-05	0.000422	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—OXCT1—osteoporosis	1.67e-05	0.000422	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.67e-05	0.000422	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—DKK1—osteoporosis	1.67e-05	0.000422	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PGLS—osteoporosis	1.66e-05	0.000419	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GPD2—osteoporosis	1.66e-05	0.000419	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—WNT1—osteoporosis	1.64e-05	0.000414	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—IDH2—osteoporosis	1.64e-05	0.000413	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—WNT1—osteoporosis	1.63e-05	0.000413	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP27A1—osteoporosis	1.63e-05	0.000412	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MGLL—osteoporosis	1.63e-05	0.000411	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ACP5—osteoporosis	1.63e-05	0.00041	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PSMA2—osteoporosis	1.62e-05	0.000408	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PSMA5—osteoporosis	1.62e-05	0.000408	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—WNT1—osteoporosis	1.61e-05	0.000406	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.61e-05	0.000405	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.6e-05	0.000404	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.6e-05	0.000403	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—FGA—osteoporosis	1.6e-05	0.000403	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—FGA—osteoporosis	1.59e-05	0.000401	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ACP5—osteoporosis	1.59e-05	0.000401	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—ADCY5—osteoporosis	1.57e-05	0.000397	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	1.57e-05	0.000395	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—FGA—osteoporosis	1.57e-05	0.000395	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	1.54e-05	0.000389	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.54e-05	0.000388	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.54e-05	0.000388	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ATIC—osteoporosis	1.52e-05	0.000383	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PNP—osteoporosis	1.52e-05	0.000383	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—TPI1—osteoporosis	1.51e-05	0.000381	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CALCA—osteoporosis	1.51e-05	0.00038	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ACP5—osteoporosis	1.5e-05	0.000377	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.5e-05	0.000377	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.49e-05	0.000376	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PTHLH—osteoporosis	1.48e-05	0.000374	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—BMP2—osteoporosis	1.48e-05	0.000374	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—BMP2—osteoporosis	1.48e-05	0.000373	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PTHLH—osteoporosis	1.48e-05	0.000373	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—TPI1—osteoporosis	1.48e-05	0.000372	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—POMC—osteoporosis	1.47e-05	0.000371	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	1.46e-05	0.000367	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—BMP2—osteoporosis	1.46e-05	0.000367	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ENO1—osteoporosis	1.45e-05	0.000367	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—FGB—osteoporosis	1.45e-05	0.000366	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—FGB—osteoporosis	1.45e-05	0.000365	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PSMA2—osteoporosis	1.43e-05	0.000361	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PSMA5—osteoporosis	1.43e-05	0.000361	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—FGB—osteoporosis	1.42e-05	0.000359	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ENO1—osteoporosis	1.42e-05	0.000359	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—P4HB—osteoporosis	1.42e-05	0.000359	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PSMA2—osteoporosis	1.4e-05	0.000354	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PSMA5—osteoporosis	1.4e-05	0.000354	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PSMA5—osteoporosis	1.4e-05	0.000354	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PSMA2—osteoporosis	1.4e-05	0.000354	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PSMA5—osteoporosis	1.4e-05	0.000352	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PSMA2—osteoporosis	1.4e-05	0.000352	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GAPDH—osteoporosis	1.4e-05	0.000352	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—TPI1—osteoporosis	1.39e-05	0.000351	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—P4HB—osteoporosis	1.39e-05	0.00035	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—IDH2—osteoporosis	1.39e-05	0.00035	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	1.38e-05	0.000347	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	1.38e-05	0.000347	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—KL—osteoporosis	1.37e-05	0.000345	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GAPDH—osteoporosis	1.36e-05	0.000344	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—RAP1A—osteoporosis	1.36e-05	0.000343	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—POMC—osteoporosis	1.33e-05	0.000337	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—RAP1A—osteoporosis	1.33e-05	0.000335	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—P4HB—osteoporosis	1.31e-05	0.00033	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CALCA—osteoporosis	1.31e-05	0.000329	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.3e-05	0.000329	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6R—osteoporosis	1.3e-05	0.000329	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CALCA—osteoporosis	1.3e-05	0.000328	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—OXCT1—osteoporosis	1.29e-05	0.000326	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CA2—osteoporosis	1.29e-05	0.000326	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GAPDH—osteoporosis	1.28e-05	0.000324	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CALCA—osteoporosis	1.28e-05	0.000323	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—POMC—osteoporosis	1.27e-05	0.000321	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—POMC—osteoporosis	1.27e-05	0.00032	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ACP5—osteoporosis	1.27e-05	0.00032	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MGLL—osteoporosis	1.26e-05	0.000317	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.25e-05	0.000316	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—RAP1A—osteoporosis	1.25e-05	0.000315	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	1.25e-05	0.000315	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—KL—osteoporosis	1.19e-05	0.000299	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.19e-05	0.000299	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—KL—osteoporosis	1.18e-05	0.000298	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—TPI1—osteoporosis	1.18e-05	0.000297	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—KL—osteoporosis	1.16e-05	0.000294	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.16e-05	0.000293	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—POMC—osteoporosis	1.16e-05	0.000292	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—POMC—osteoporosis	1.15e-05	0.000291	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.14e-05	0.000287	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.13e-05	0.000286	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.13e-05	0.000285	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6R—osteoporosis	1.12e-05	0.000284	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—P4HB—osteoporosis	1.11e-05	0.000279	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.11e-05	0.000279	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ENO1—osteoporosis	1.1e-05	0.000277	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GAPDH—osteoporosis	1.09e-05	0.000274	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PSMA2—osteoporosis	1.08e-05	0.000273	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PSMA5—osteoporosis	1.08e-05	0.000273	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ENO1—osteoporosis	1.07e-05	0.000271	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.07e-05	0.00027	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—IDH2—osteoporosis	1.07e-05	0.00027	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—RAP1A—osteoporosis	1.06e-05	0.000267	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PSMA5—osteoporosis	1.06e-05	0.000267	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PSMA2—osteoporosis	1.06e-05	0.000267	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.04e-05	0.000262	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ENO1—osteoporosis	1.01e-05	0.000255	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.01e-05	0.000254	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PSMA2—osteoporosis	9.96e-06	0.000251	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PSMA5—osteoporosis	9.96e-06	0.000251	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ACP5—osteoporosis	9.78e-06	0.000247	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ADCY5—osteoporosis	9.5e-06	0.00024	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GPX1—osteoporosis	9.46e-06	0.000239	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IRS2—osteoporosis	9.38e-06	0.000237	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ADCY5—osteoporosis	9.3e-06	0.000235	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ADCY5—osteoporosis	9.29e-06	0.000234	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GPX1—osteoporosis	9.27e-06	0.000234	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ADCY5—osteoporosis	9.26e-06	0.000234	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.23e-06	0.000233	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—LEP—osteoporosis	9.18e-06	0.000232	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	9.12e-06	0.00023	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TPI1—osteoporosis	9.09e-06	0.000229	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SPP1—osteoporosis	8.99e-06	0.000227	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SPP1—osteoporosis	8.96e-06	0.000226	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SPP1—osteoporosis	8.82e-06	0.000222	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYP19A1—osteoporosis	8.78e-06	0.000222	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ESR1—osteoporosis	8.76e-06	0.000221	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—MTHFR—osteoporosis	8.73e-06	0.00022	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP19A1—osteoporosis	8.57e-06	0.000216	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ENO1—osteoporosis	8.56e-06	0.000216	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—MTHFR—osteoporosis	8.55e-06	0.000216	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—P4HB—osteoporosis	8.55e-06	0.000216	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PSMA5—osteoporosis	8.43e-06	0.000213	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PSMA2—osteoporosis	8.43e-06	0.000213	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GAPDH—osteoporosis	8.39e-06	0.000212	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IRS1—osteoporosis	8.19e-06	0.000207	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—RAP1A—osteoporosis	8.17e-06	0.000206	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IRS2—osteoporosis	8.13e-06	0.000205	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IRS2—osteoporosis	8.1e-06	0.000204	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.08e-06	0.000204	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IRS2—osteoporosis	7.98e-06	0.000201	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—LEP—osteoporosis	7.95e-06	0.000201	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—LEP—osteoporosis	7.93e-06	0.0002	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—POMC—osteoporosis	7.89e-06	0.000199	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—LEP—osteoporosis	7.8e-06	0.000197	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6R—osteoporosis	7.69e-06	0.000194	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ESR1—osteoporosis	7.59e-06	0.000192	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IGF1—osteoporosis	7.58e-06	0.000191	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ESR1—osteoporosis	7.57e-06	0.000191	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ESR1—osteoporosis	7.45e-06	0.000188	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ADCY5—osteoporosis	7.18e-06	0.000181	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GPX1—osteoporosis	7.15e-06	0.00018	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IRS1—osteoporosis	7.1e-06	0.000179	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IRS1—osteoporosis	7.07e-06	0.000178	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ADCY5—osteoporosis	7e-06	0.000177	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—POMC—osteoporosis	6.98e-06	0.000176	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GPX1—osteoporosis	6.98e-06	0.000176	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IRS1—osteoporosis	6.96e-06	0.000176	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP19A1—osteoporosis	6.84e-06	0.000173	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—POMC—osteoporosis	6.84e-06	0.000173	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—POMC—osteoporosis	6.83e-06	0.000172	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—POMC—osteoporosis	6.81e-06	0.000172	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—POMC—osteoporosis	6.7e-06	0.000169	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6R—osteoporosis	6.66e-06	0.000168	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6R—osteoporosis	6.64e-06	0.000168	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ENO1—osteoporosis	6.61e-06	0.000167	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ADCY5—osteoporosis	6.6e-06	0.000167	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MTHFR—osteoporosis	6.6e-06	0.000167	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GPX1—osteoporosis	6.58e-06	0.000166	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF1—osteoporosis	6.57e-06	0.000166	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF1—osteoporosis	6.55e-06	0.000165	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6R—osteoporosis	6.54e-06	0.000165	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PSMA2—osteoporosis	6.51e-06	0.000164	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PSMA5—osteoporosis	6.51e-06	0.000164	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF1—osteoporosis	6.45e-06	0.000163	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MTHFR—osteoporosis	6.44e-06	0.000163	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MTHFR—osteoporosis	6.07e-06	0.000153	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—osteoporosis	5.8e-06	0.000146	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ADCY5—osteoporosis	5.59e-06	0.000141	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GPX1—osteoporosis	5.57e-06	0.000141	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.28e-06	0.000133	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—POMC—osteoporosis	5.28e-06	0.000133	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—POMC—osteoporosis	5.15e-06	0.00013	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MTHFR—osteoporosis	5.14e-06	0.00013	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—osteoporosis	5.03e-06	0.000127	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—osteoporosis	5.01e-06	0.000126	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—osteoporosis	4.93e-06	0.000124	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—POMC—osteoporosis	4.85e-06	0.000122	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MYC—osteoporosis	4.56e-06	0.000115	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TGFB1—osteoporosis	4.55e-06	0.000115	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ADCY5—osteoporosis	4.32e-06	0.000109	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GPX1—osteoporosis	4.3e-06	0.000108	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—POMC—osteoporosis	4.11e-06	0.000104	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MTHFR—osteoporosis	3.97e-06	0.0001	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MYC—osteoporosis	3.95e-06	9.97e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TGFB1—osteoporosis	3.94e-06	9.94e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MYC—osteoporosis	3.94e-06	9.93e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TGFB1—osteoporosis	3.93e-06	9.91e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MYC—osteoporosis	3.88e-06	9.78e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	3.87e-06	9.75e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—osteoporosis	3.43e-06	8.64e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—POMC—osteoporosis	3.17e-06	8.01e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—osteoporosis	2.97e-06	7.49e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—osteoporosis	2.96e-06	7.47e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—osteoporosis	2.91e-06	7.35e-05	CbGpPWpGaD
